0000902664-22-002143.txt : 20220311 0000902664-22-002143.hdr.sgml : 20220311 20220311135439 ACCESSION NUMBER: 0000902664-22-002143 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(1) FILED AS OF DATE: 20220311 DATE AS OF CHANGE: 20220311 EFFECTIVENESS DATE: 20220311 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MSD Growth Fund, L.P. CENTRAL INDEX KEY: 0001869385 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-406683 FILM NUMBER: 22732371 BUSINESS ADDRESS: STREET 1: ONE VANDERBILT AVENUE STREET 2: 26TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 212-303-1650 MAIL ADDRESS: STREET 1: ONE VANDERBILT AVENUE STREET 2: 26TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 FORMER COMPANY: FORMER CONFORMED NAME: MSD EIV Growth, LLC DATE OF NAME CHANGE: 20210624 D/A 1 primary_doc.xml X0708 D/A LIVE 0001869385 MSD Growth Fund, L.P. ONE VANDERBILT AVENUE 26TH FLOOR NEW YORK NY NEW YORK 10017 212-303-1650 DELAWARE None MSD EIV Growth, LLC Limited Liability Company true 2021 - MSD Partners (GP) - Growth, LLC One Vanderbilt Avenue 26th Floor New York NY NEW YORK 10017 Executive Officer General Partner Marc R. Lisker One Vanderbilt Avenue 26th Floor New York NY NEW YORK 10017 Executive Officer Managing Director of the General Partner John Phelan One Vanderbilt Avenue 26th Floor New York NY NEW YORK 10017 Executive Officer Managing Director of the General Partner Brendan Rogers One Vanderbilt Avenue 26th Floor New York NY NEW YORK 10017 Executive Officer Managing Director of the General Partner - MSD Partners, L.P. One Vanderbilt Avenue 26th Floor New York NY NEW YORK 10017 Promoter Investment Manager Pooled Investment Fund Other Investment Fund false Decline to Disclose 06b 3C 3C.1 true 0000902664-21-003559 2021-05-14 true true false 0 Indefinite 120900000 Indefinite false 72 0 0 0 false MSD Growth Fund, L.P. /s/ Robert Simonds Robert Simonds Authorized Signatory 2022-03-11